drugset
drugset / Trial / NCT03133195

The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA

NCT03133195 ↗

Phase 3 Completed 50 enrolled King Chulalongkorn Memorial Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase III, prospective, randomized, parallel, double blind, placebo-controlled study to determine whether Teriparatide can accelerate bone healing in unstable intertrochanteric fracture patients treated with Proximal Femoral Nail Antirotation (PFNA) assessed by radiographic and clinical outcomes.

Timeline

Start
2017-05-17
Primary completion
2022-06-01
Completion
2023-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug Subcutaneous

Indications

No indication recorded.